Chronic DVT ‐ antiplatelet agents plus BMP vs BMP plus placebo
Adverse events · people requiring treatment for chronic DVT
Chronic DVT ‐ antiplatelet agents plus BMP showed no clear difference in adverse events compared with BMP plus placebo (moderate certainty).
1 finding from 1 review
- Antiplatelet agents for the treatment of deep venous thrombosis 2022 · Cochrane Headline outcomes onlyRR 1.57 [0.34, 7.19]2 studies · 621 participantsModerate